|Involvement of the Ink4a gene (p16 and p19arf) in murine tumorigenesis.|
Authors: I Orlow, F Rabbani, L Chin, J Pomerantz, N Ligeois, M Dudas, R Depinho, C Cordón-Cardó
Affiliations: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
The INK4A and INK4B genes map to 9p21, with the INK4A gene encoding two products, p16 and p19ARF. Many neoplasms in which INK4A and INK4B genes are altered show deletions involving both genes. Mice carrying a targeted Ink4a deletion develop tumors at an early age. In the present study we examined the genetic alterations affecting the remaining Ink4a allele and the Ink4b gene in tumors arising in heterozygous Ink4a mice. We identified deletion of the remaining Ink4a allele in 7 of 18 (39%) tumors. We also observed deletion of the exon 1beta in 3 cases, one of them presenting this deletion as a unique alteration. In conclusion, the deletion of the remaining Ink4a allele was the alteration most frequently observed, representing the inactivation of two proteins capable of arresting the cell cycle through different pathways that involve the tumor suppressors pRB and p53.